Evolution of human H3N2 influenza virus receptor specificity has substantially expanded the receptor-binding domain site
Cell Host & Microbe · 2024
DOI: 10.1016/j.chom.2024.01.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Host & Microbe, 2024. Verfasst von Andrew J Thompson und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA. Hauptthemen laut MEDLINE: Influenza A Virus, H3N2 Subtype, Influenza, Human. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Basque Foundation for Science, Universidad Complutense de Madrid.
Abstract (Originalsprache)
Hemagglutinins (HAs) from human influenza viruses descend from avian progenitors that bind α2-3-linked sialosides and must adapt to glycans with α2-6-linked sialic acids on human airway cells to transmit within the human population. Since their introduction during the 1968 pandemic, H3N2 viruses have evolved over the past five decades to preferentially recognize human α2-6-sialoside receptors that are elongated through addition of poly-LacNAc. We show that more recent H3N2 viruses now make increasingly complex interactions with elongated receptors while continuously selecting for strains maintaining this phenotype. This change in receptor engagement is accompanied by an extension of the traditional receptor-binding site to include residues in key antigenic sites on the surface of HA trimers. These results help explain the propensity for selection of antigenic variants, leading to vaccine mismatching, when H3N2 viruses are propagated in chicken eggs or cells that do not contain such receptors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA.
- Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
- Department of Organic Chemistry, Faculty of Chemistry, Universidad Complutense de Madrid, Avd. Complutense s/n, 28040 Madrid, Spain.
- Structural and Chemical Biology Department, Centro de Investigaciones Biológicas Margarita Salas, C/Ramiro de Maeztu 9, 28040 Madrid, Spain.
- Structural and Chemical Biology Department, Centro de Investigaciones Biológicas Margarita Salas, C/Ramiro de Maeztu 9, 28040 Madrid, Spain; CIBERES, ISCIII, 28029 Madrid, Spain.
- CIBERES, ISCIII, 28029 Madrid, Spain; CIC bioGUNE Bizkaia Science and Technology Park, 48160 Bilbao, Spain; IKERBASQUE, Basque Foundation for Science, 48009 Bilbao, Spain.
Förderung
- NIAID NIH HHS
- Basque Foundation for Science
- Universidad Complutense de Madrid
- ISCIII
- National Institutes of Health
- Bill and Melinda Gates Foundation
- Scripps Research Institute
- Ministerio de Ciencia e Innovación
Zitieren
APA
Thompson, A. J., Wu, N. C., Canales, A., Kikuchi, C., Zhu, X., de Toro, B. F., Cañada, F. J., Worth, C., Wang, S., McBride, R., Peng, W., Nycholat, C. M., Jiménez-Barbero, J., Wilson, I. A., & Paulson, J. C. (2024). Evolution of human H3N2 influenza virus receptor specificity has substantially expanded the receptor-binding domain site. Cell Host & Microbe. https://doi.org/10.1016/j.chom.2024.01.003
Vancouver
Thompson AJ, Wu NC, Canales A, Kikuchi C, Zhu X, de Toro BF, et al. Evolution of human H3N2 influenza virus receptor specificity has substantially expanded the receptor-binding domain site. Cell Host & Microbe. 2024. doi:10.1016/j.chom.2024.01.003
BibTeX
@article{Thompson2024,
author = {Thompson, Andrew J and Wu, Nicholas C and Canales, Angeles and Kikuchi, Chika and Zhu, Xueyong and de Toro, Beatriz Fernández and Cañada, Francisco J and Worth, Charli and Wang, Shengyang and McBride, Ryan and Peng, Wenjie and Nycholat, Corwin M and Jiménez-Barbero, Jesús and Wilson, Ian A and Paulson, James C},
title = {Evolution of human H3N2 influenza virus receptor specificity has substantially expanded the receptor-binding domain site},
journal = {Cell Host & Microbe},
year = {2024},
doi = {10.1016/j.chom.2024.01.003}
}
EUVIMED